Acasă › Leucemie mieloasă acută › Tennessee › Nashville
Studii clinice pentru Leucemie mieloasă acută în Nashville, TN
21 studii pentru Leucemie mieloasă acută caută participanți în și în jurul orașului Nashville (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 1
- Tristar Centennial Medical Center /ID# 275831, Nashville
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- Vanderbilt Ingram Cancer Center, Nashville
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
În curs de recrutareFaza 3
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
În curs de recrutareFaza 1
- Sarah Cannon Center for Blood Cancer at TriStar Centennia, Nashville
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
În curs de recrutareFaza 3
- The Children's Hospital at TriStar Centennial, Nashville
CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)
În curs de recrutareFaza 1
- Sarah Cannon Research Insitute, Nashville
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
În curs de recrutareFaza 1/2
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
În curs de recrutareFaza 3
- Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
În curs de recrutareFaza 3
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Vanderbilt University Medical Center, Nashville
Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
În curs de recrutareFaza 1
- Vanderbilt University/Ingram Cancer Center, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
În curs de recrutareFaza 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
În curs de recrutareStudiu observațional
- Vanderbilt University, Nashville
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
În curs de recrutareFaza 2/3
- Vanderbilt University Medical Center, Nashville
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
În curs de recrutareFaza 1/2
- TriStar Centennial Medical Center, Nashville
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
În curs de recrutareFaza 1
- Sarah Cannon Cancer Institute, Nashville
- Vanderbilt University Medical Center, Nashville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
În curs de recrutareFaza 1
- TriStar Bone Marrow Transplant, Nashville
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
În curs de recrutareFaza 1
- Vanderbilt University, Nashville
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
În curs de recrutareFaza 1
- Sarah Cannon Research Institute, Nashville
HPC Offered for PRESERVE Expansion
În curs de recrutareStudiu observațional
- Tristar Centennial Medical Center, Nashville
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
În curs de recrutareFaza 1
- TriStar Bone Marrow Transplant, Nashville
Studii pentru Leucemie mieloasă acută în alte orașe
- Houston, TX85 studii
- New York City, NY51 studii
- Boston, MA44 studii
- Seattle, WA41 studii
- Baldwin Park, CA40 studii
- Columbus, OH35 studii
- Philadelphia, PA34 studii
- Durham, NC33 studii
- Atlanta, GA31 studii
- Tampa, FL29 studii
- Chicago, IL26 studii
- Portland, OR25 studii
Alte studii în Nashville
- Cancer pulmonar cu celule non-pătrate97 studii
- Cancer de sân81 studii
- Cancer metastatic70 studii
- Cancer colorectal69 studii
- Cancer (toate tipurile)65 studii
- Cancer ovarian49 studii
- Cancer de prostată43 studii
- Cancer pulmonar40 studii
- Carcinom cu celule scuamoase de cap și gât39 studii
- Cancer pancreatic39 studii
- Cancer endometrial38 studii
- Melanom33 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.